Biggest News Aggregation in the World
📰 Rna News

Page 34 - Rna News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rna. Real-time updates on events, politics, business and more.

Short Interest in Avidity Biosciences, Inc. (NASDAQ:RNA) Expands By 25.5%

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Rating) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totalling 10,910,000 shares, a growth of 25.5% from the March 15th total of 8,690,000 shares. Based on an average daily volume of 1,040,000 shares, the days-to-cover ratio is […]
Arthura Levin Sarah Boyce Wells Fargo Company Needham Company Securities Exchange Commission Itau Unibanco Holding
Source: wkrb13.com

Moderna, Inc.: Moderna and Merck Announce mRNA-4157 , an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA , Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete R

MRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients with high risk of recurrence following complete
United States United Kingdom Mary Beth Woodin Peter Dannenbaum Lavina Talukdar Justine Moore

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Pfizers new bivalent mRNA Covid booster vax highly effective: Lancet

Jerusalem, April 14: US pharma giant Pfizers new bivalent mRNA-based Covid booster vaccine has shown to be highly effective in reducing hospitalisation and deaths, particularly in vulnerable patients aged 65 years and above, according to a study published in The Lancet Infectious Diseases.
Israel General Lancet Infectious Pfizers New Bivalent Mrna Covid Booster Vax Highly Effective Lancet

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science